Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, Omnia Kutkat, Radwan Alnajjar, Ahmed N. El-Taweel, Sara T. Al-Rashood, Mohammed A.S. Abourehab, Faizah A. Binjubair, Mohamed A. Saleh, Amany Belal, Ahmed A. Al-Karmalawy
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies'. Together they form a unique fingerprint.